Evolution of the gynecologic oncology group protocols in the treatment of epithelial ovarian cancer

Leigh G. Seamon, Debra L. Richardson, Larry J. Copeland

Research output: Contribution to journalReview article

9 Scopus citations

Abstract

This chapter reviews some of the sentinel Gynecologic Oncology Group (GOG) ovarian trials, describes their rationale, provides summary tables for reference, and is organized into early ovarian cancer (GOG 1, 7601, 7602, 95, 157, 175, 212), advanced ovarian cancer optimal (2, 25, 52, 104, 114, 158, 172, 182, 178, 212, 252), and suboptimal disease (3, 22, 47, 97, 111, 162, 182, 218, 252, 262).

Original languageEnglish (US)
Pages (from-to)131-135
Number of pages5
JournalClinical Obstetrics and Gynecology
Volume55
Issue number1
DOIs
StatePublished - Mar 1 2012

Keywords

  • GOG
  • Gynecologic Oncology Group
  • clinical trials
  • ovarian cancer
  • review

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Evolution of the gynecologic oncology group protocols in the treatment of epithelial ovarian cancer'. Together they form a unique fingerprint.

  • Cite this